-
- Posts: 17
- Joined: Sun Jan 23, 2011 10:00 am
It has been quite long since my last post!!. I have a question,
In our drug product related substance chromatogram there are some peaks observed sample as well as in placebo. However, the peak response is higher in the sample (40 to 50% higher). Should we have to report it? Anybody faced such issues?. How to go ahead about that?
Appreciate valid responses,
Thanks
Vijayak